The biotechnology trial of the century over CRISPR patent settled in US court – Courier Mail
Courier Mail |
The biotechnology trial of the century over CRISPR patent settled in US court
Courier Mail The emergence of inexpensive and accurate gene-editing technology, known as CRISPR/Cas9, has fuelled “an explosion of new research opportunities and potential clinical applications, both heritable and non-heritable, to address a wide range of human … |
